IL2 and hereditary clear cell renal cell carcinoma: The use of high-dose IL-2 in renal cell carcinoma and melanoma are two rare instances in oncology where an effective treatment has been identified to potentially cure a widely metastatic solid tumor (Gaffen & Liu, 2004).